Diversify Wealth Management LLC Boosts Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Diversify Wealth Management LLC raised its holdings in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 35.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 10,399 shares of the company’s stock after buying an additional 2,713 shares during the period. Diversify Wealth Management LLC’s holdings in Prestige Consumer Healthcare were worth $770,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Martingale Asset Management L P grew its position in shares of Prestige Consumer Healthcare by 0.4% during the 3rd quarter. Martingale Asset Management L P now owns 36,971 shares of the company’s stock valued at $2,666,000 after acquiring an additional 140 shares during the period. Horizon Kinetics Asset Management LLC grew its holdings in Prestige Consumer Healthcare by 4.8% during the third quarter. Horizon Kinetics Asset Management LLC now owns 3,247 shares of the company’s stock valued at $234,000 after purchasing an additional 150 shares during the period. Evergreen Capital Management LLC increased its position in Prestige Consumer Healthcare by 5.4% in the second quarter. Evergreen Capital Management LLC now owns 3,143 shares of the company’s stock worth $216,000 after buying an additional 160 shares in the last quarter. OLD National Bancorp IN raised its stake in shares of Prestige Consumer Healthcare by 4.4% in the third quarter. OLD National Bancorp IN now owns 3,974 shares of the company’s stock worth $287,000 after buying an additional 168 shares during the period. Finally, Huntington National Bank lifted its position in shares of Prestige Consumer Healthcare by 39.9% during the 3rd quarter. Huntington National Bank now owns 635 shares of the company’s stock valued at $46,000 after buying an additional 181 shares in the last quarter. 99.95% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

PBH has been the subject of several analyst reports. Jefferies Financial Group reissued a “hold” rating and issued a $76.00 target price (up from $70.00) on shares of Prestige Consumer Healthcare in a report on Tuesday, September 24th. DA Davidson reissued a “buy” rating and issued a $95.00 price objective on shares of Prestige Consumer Healthcare in a research note on Monday, November 11th. StockNews.com cut shares of Prestige Consumer Healthcare from a “buy” rating to a “hold” rating in a research note on Thursday, January 16th. Raymond James upgraded Prestige Consumer Healthcare to a “moderate buy” rating in a research note on Thursday, December 19th. Finally, Sidoti downgraded Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 price objective on the stock. in a research report on Monday, December 9th. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, Prestige Consumer Healthcare has a consensus rating of “Hold” and an average price target of $85.25.

Prestige Consumer Healthcare Stock Up 1.0 %

Shares of PBH stock opened at $79.36 on Wednesday. The company’s fifty day simple moving average is $80.46 and its two-hundred day simple moving average is $74.66. Prestige Consumer Healthcare Inc. has a 52 week low of $59.38 and a 52 week high of $86.36. The stock has a market cap of $3.92 billion, a P/E ratio of 19.31, a PEG ratio of 2.20 and a beta of 0.51. The company has a quick ratio of 2.10, a current ratio of 3.56 and a debt-to-equity ratio of 0.61.

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings results on Thursday, November 7th. The company reported $1.09 EPS for the quarter, meeting analysts’ consensus estimates of $1.09. Prestige Consumer Healthcare had a return on equity of 12.23% and a net margin of 18.54%. The company had revenue of $283.79 million during the quarter, compared to analyst estimates of $282.09 million. During the same period in the prior year, the company earned $1.07 earnings per share. The firm’s revenue was down .9% on a year-over-year basis. Analysts predict that Prestige Consumer Healthcare Inc. will post 4.46 EPS for the current fiscal year.

Insider Buying and Selling

In other news, EVP Adel Mekhail sold 9,063 shares of the business’s stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $82.00, for a total value of $743,166.00. Following the sale, the executive vice president now directly owns 18,365 shares in the company, valued at $1,505,930. The trade was a 33.04 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Ronald M. Lombardi sold 10,875 shares of the company’s stock in a transaction dated Tuesday, November 19th. The shares were sold at an average price of $82.60, for a total transaction of $898,275.00. Following the sale, the chief executive officer now owns 320,952 shares in the company, valued at $26,510,635.20. This represents a 3.28 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 38,810 shares of company stock worth $3,187,300. Insiders own 1.60% of the company’s stock.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.